PLC’s clinical and regulatory support, including a successful FDA Fast Track designation status for naloxone nasal spray for Adapt Pharmaceuticals resulted in NARCAN®’s approval by the FDA. NARCAN is a needle-free, intranasal spray that can be used to treat opioid drug overdose. NARCAN® (naloxone hydrochloride) Nasal Spray approved by U.S. food and drug administration November

The Pacific Link Consulting Team has a combined total of 50 + years of experience in the Regulatory Services field, Clinical Trial planning and execution, tracking and filing as well as robust experience developing new products for the US, European and Japanese markets. Clinical Trials Regulatory Services Product Development